Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new review of previous studies into the long-term effects of childhood sexual abuse has suggested that earlier mental health support for victims would reduce the chances of victims developing psychiatric conditions and substance misuse later in life.

None © Shutterstock

Childhood sexual abuse is known to be associated with a wide range of health conditions, from chronic pain to mental health problems. There have been many studies examining these links but these typically looked at one outcome in adulthood, and there has not been a synthesis examining the full breadth of international research evidence and its quality.

A new review of these previous studies led by Oxford University researchers, suggests that pre-emptive interventions for victims and survivors of childhood sexual abuse should be prioritised to reduce the chances of victims developing common psychiatric conditions and substance misuse.

The researchers from the University’s Department of Psychiatry looked at quantitative reviews that used transparent and systematic searching strategies, also known as meta-analyses, of the research examining the chance of developing adult health conditions and psychosocial problems following childhood sexual abuse.

Read more (University of Oxford website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.